EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access

Effectiveness of Radiomics-Based Machine Learning Models in Differentiating Pancreatitis and Pancreatic Ductal Adenocarcinoma: Systematic Review and Meta-Analysis

Wirksamkeit radiomischer Machine-Learning-Modelle zur Unterscheidung von Pankreatitis und Pankreasgangadenokarzinom: systematische Übersichtsarbeit und Metaanalyse

Lechang Zhang, Dewei Li, Tong Su, Tong Xiao, Shulei Zhao

Journal of Medical Internet Research · 31.07.2025 · 27 · e72420-e72420

DOI: 10.2196/72420 ↗

Auf einen Blick

24 Studien zeigen eine hohe diagnostische Leistung radiombasierter ML-Modelle zur Unterscheidung von PDAC und massenbildender Pankreatitis. Die Modelle erreichten in der unabhängigen Validierung hohe Sensitivität und Spezifität.

Fragestellung

Wie gut unterscheiden radiombasierte Machine-Learning-Modelle PDAC von massenbildender Pankreatitis?

Methode

Systematische Übersichtsarbeit und Metaanalyse; Suche in PubMed, Embase, Cochrane und Web of Science bis 29. Juni 2024; Qualitätsbewertung mit Radiomics Quality Score.

Ergebnisse

24 Studien mit 14.406 Fällen, darunter 7.635 PDAC-Fälle. Gepoolt in unabhängigen Validierungssets: Sensitivität 0,92 (95 %-KI 0,91–0,94), Spezifität 0,90 (95 %-KI 0,85–0,94), AUC 0,94 (95 %-KI 0,74–0,99).

Einschränkungen

Methodische Qualität insgesamt moderat; Einschränkungen bei externer Validierung, standardisierten Protokollen und Reproduzierbarkeit.

Schlussfolgerung der Autor:innen

Radiombasierte ML-Modelle zeigen eine hohe diagnostische Genauigkeit zur Unterscheidung von PDAC und MFP. Die Autor:innen sehen weiteres, strengeres multizentrisches Forschungsbedürfnis.

Kernaussagen

  • Hohe diagnostische Leistung radiombasierter ML-Modelle
  • Sensitivität 0,92 und Spezifität 0,90
  • Methodische Qualität insgesamt nur moderat

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Medical Internet Research, online erschienen am 31.07.2025. Verfasst von Lechang Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwu Weiqi Rd, Jinan, 250021, Chi…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Machine Learning, Pancreatic Neoplasms, Pancreatitis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic ductal adenocarcinoma (PDAC) and mass-forming pancreatitis (MFP) share similar clinical, laboratory, and imaging features, making accurate diagnosis challenging. Nevertheless, PDAC is highly malignant with a poor prognosis, whereas MFP is an inflammatory condition typically responding well to medical or interventional therapies. Some investigators have explored radiomics-based machine learning (ML) models for distinguishing PDAC from MFP. However, systematic evidence supporting the feasibility of these models is insufficient, presenting a notable challenge for clinical application.

Objective

This study intended to review the diagnostic performance of radiomics-based ML models in differentiating PDAC from MFP, summarize the methodological quality of the included studies, and provide evidence-based guidance for optimizing radiomics-based ML models and advancing their clinical use.

Methods

PubMed, Embase, Cochrane, and Web of Science were searched for relevant studies up to June 29, 2024. Eligible studies comprised English cohort, case-control, or cross-sectional designs that applied fully developed radiomics-based ML models—including traditional and deep radiomics—to differentiate PDAC from MFP, while also reporting their diagnostic performance. Studies without full text, limited to image segmentation, or insufficient outcome metrics were excluded. Methodological quality was appraised by means of the radiomics quality score. Since the limited applicability of QUADAS-2 in radiomics-based ML studies, the risk of bias was not formally assessed. Pooled sensitivity, specificity, area under the curve of summary receiver operating characteristics (SROC), likelihood ratios, and diagnostic odds ratio were estimated through a bivariate mixed-effects model. Results were presented with forest plots, SROC curves, and Fagan’s nomogram. Subgroup analysis was performed to appraise the diagnostic performance of radiomics-based ML models across various imaging modalities, including computed tomography (CT), magnetic resonance imaging, positron emission tomography-CT, and endoscopic ultrasound.

Results

This meta-analysis included 24 studies with 14,406 cases, including 7635 PDAC cases. All studies adopted a case-control design, with 5 conducted across multiple centers. Most studies used CT as the primary imaging modality. The radiomics quality score scores ranged from 5 points (14%) to 17 points (47%), with an average score of 9 (25%). The radiomics-based ML models demonstrated high diagnostic performance. Based on the independent validation sets, the pooled sensitivity, specificity, area under the curve of SROC, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were 0.92 (95% CI 0.91‐0.94), 0.90 (95% CI 0.85‐0.94), 0.94 (95% CI 0.74‐0.99), 9.3 (95% CI 6.0‐14.2), 0.08 (95% CI 0.07‐0.11), and 110 (95% CI 62‐194), respectively.

Conclusions

Radiomics-based ML models demonstrate high diagnostic accuracy in differentiating PDAC from MFP, underscoring their potential as noninvasive tools for clinical decision-making. Nonetheless, the overall methodological quality was moderate due to limitations in external validation, standardized protocols, and reproducibility. These findings support the promise of radiomics in clinical diagnostics while highlighting the need for more rigorous, multicenter research to enhance model generalizability and clinical applicability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalMachine LearningPancreatic NeoplasmsPancreatitisHumansDiagnosis, DifferentialRadiomics

Stichwörter der Autor:innen

artificial intelligencedifferential diagnosisimaging modalitiesmeta-analysissystematic review

Autor:innen und Institutionen

  • Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwu Weiqi Rd, Jinan, 250021, China, 86 13853121769.
  • Department of Infectious Diseases, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.

Zitieren

APA

Zhang, L., Li, D., Su, T., Xiao, T., & Zhao, S. (2025). Effectiveness of Radiomics-Based Machine Learning Models in Differentiating Pancreatitis and Pancreatic Ductal Adenocarcinoma: Systematic Review and Meta-Analysis. Journal of Medical Internet Research, 27, e72420-e72420. https://doi.org/10.2196/72420

Vancouver

Zhang L, Li D, Su T, Xiao T, Zhao S. Effectiveness of Radiomics-Based Machine Learning Models in Differentiating Pancreatitis and Pancreatic Ductal Adenocarcinoma: Systematic Review and Meta-Analysis. Journal of Medical Internet Research. 2025;27:e72420-e72420. doi:10.2196/72420

BibTeX
@article{Zhang2025,
  author = {Zhang, Lechang and Li, Dewei and Su, Tong and Xiao, Tong and Zhao, Shulei},
  title = {Effectiveness of Radiomics-Based Machine Learning Models in Differentiating Pancreatitis and Pancreatic Ductal Adenocarcinoma: Systematic Review and Meta-Analysis},
  journal = {Journal of Medical Internet Research},
  year = {2025},
  volume = {27},
  pages = {e72420--e72420},
  doi = {10.2196/72420}
}
Kostenlos starten →